Global access to genetic testing unequal; Indian expert calls for policy framework to make precision cancer care affordable
By United One News · AI-generated summary of 1 outlets' reporting
Published
AI-generated summary of the coverage listed below:
- A Lancet Oncology commission reports that only 2% of biomarker‑based cancer trials occur in low‑ and middle‑income countries.
- The Indian oncologist calls for a five‑year policy agenda to increase access to advanced genetic testing and precision cancer therapies in India.
Covered by 1 outlet across the spectrum: 0% left, 100% center, 0% right.
How each side framed it
Global access to genetic testing unequal; Indian expert calls for policy framework to make precision cancer care affordable
Timeline
First reported by Deccan Herald on ; 1 article from 1 outlets so far.
Who is covering this story
- Center (1): Deccan Herald